Home Search
epilepsy - search results
If you're not happy with the results, please do another search
Hannah Deacon – Maple Tree Consultancy
Hannah Deacon is the mother of Alfie Dingley, a six-year-old boy with a rare form of epilepsy. When Hannah and Alfie moved to Holland for five months to access medicine containing THC, Alfie’s condition improved dramatically, after which Hannah became the first person to legally enter UK with cannabis...
A comprehensive guide to CBD in the UK
Here, Professor Mike Barnes discusses and answers some key questions about the world of CBD in the UK.
Ensuring a high and reproducible quality of medicinal cannabis
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Sue Houston – Christchurch Group
Sue Houston, Group Chief Nursing Officer, Christchurch Group - Registered Nurse, Diploma (BSc) in Epilepsy, Best Interest Assessor.
Can lavender aid those who struggle with insomnia?
Dr Deborah Lee, Dr Fox Online Pharmacy, explores how aromatherapy is fast emerging as a form of alternative medicine for many health conditions, including insomnia.
How are different types of medical cannabis working for different diseases?
Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
How cannabinoids can be used as pain medicine
Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
Attracting major investors: GreenLight on the international stage
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
Cannabinoids in medicine part 5: Treating COVID-19
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
New study shows CBD treatment may help treat pain, anxiety, and depression
Here, OilsBySimpson explains the findings of a new study on 400 patients prescribed cannabidiol (CBD). The results show promise for pain, anxiety, and depression.
COVID-19 and medical cannabis: Could the crisis bring opportunities?
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
Removing the barriers to ensure a thriving UK hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance, explains what we need to know about removing the barriers to ensure a thriving UK hemp industry.
Cannabis (hemp): The effect of terpenes in CBD full extracts
Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.
Controlling and preventing diseases: A focus on traumatic brain injury
The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
European Medicines Agency and orphan designation
Here, we discover that the European Medicines Agency works to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public and animal health in the European Union.
The pharmaceutical industry in Europe
Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.
Medical use of cannabinoids and marijuana
In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
A World Health Organization perspective on cannabidiol (CBD)
Here, we discover the World Health Organization perspective on cannabidiol (CBD), including how there has been a shift in how CBD is socially perceived following reports and recommendations.
IP protection in fast-moving global markets: Medical cannabis & CBD
Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
